Sfoglia per Autore ALBERICI, Federico
The role of analytical methods for the determination of trace elements in environmental biomonitors
2002-01-01 Bettinelli, M.; Perotti, M.; Spezia, S.; Baffi, C.; Beone, G. M.; Alberici, F.; Bergonzi, S.; Bettinelli, C.; Cantarini, P.; Mascetti, L.
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC)
2007-01-01 Buti, S.; Brighenti, M.; Bongiovanni, C.; Buzio, C.; Chiesa, M. D.; Alberici, F.; Passalacqua, R.
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile
2008-01-01 Vaglio, A.; Alberici, F.; Maggiore, U.; Buti, S.; Potenzoni, D.; Passalacqua, R.; Buzio, C.
Peripheral inflammatory arthritis in patients with chronic periaortitis: Report of five cases and review of the literature
2008-01-01 Vaglio, A.; Palmisano, A.; Ferretti, S.; Alberici, Federico; Casazza, I.; Salvarani, C.; Buzio, C.
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-α in patients with renal cell carcinoma
2009-01-01 Pavone, L.; Fanti, G.; Bongiovanni, C.; Goldoni, M.; Alberici, F.; Bonomini, S.; Cristinelli, L.; Buzio, C.
Chronic periaortitis associated with membranous nephropathy: Clues to common pathogenetic mechanisms
2010-01-01 Palmisano, A.; Corradi, D.; Carnevali, M. L.; Alberici, F.; Silini, E. M.; Gatti, R.; Allegri, L.; Buzio, C.; Vaglio, A.
A cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis
2011-01-01 Suppiah, R.; Mukhtyar, C.; Flossmann, O.; Alberici, F.; Baslund, B.; Batra, R.; Brown, D.; Holle, J.; Hruskova, Z.; Jayne, D. R. W.; Judge, A.; Little, M. A.; Palmisano, A.; Stegeman, C.; Tesar, V.; Vaglio, A.; Westman, K.; Luqmani, R.
Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
2011-01-01 Suppiah, R.; Flossmann, O.; Mukhtyar, C.; Alberici, F.; Baslund, B.; Brown, D.; Hasan, N.; Holle, J.; Hruskova, Z.; Jayne, D.; Judge, A.; Little, M. A.; Merkel, P. A.; Palmisano, A.; Seo, P.; Stegeman, C.; Tesar, V.; Vaglio, A.; Westman, K.; Luqmani, R.
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: An open-label randomised controlled trial
2011-01-01 Vaglio, A.; Palmisano, A.; Alberici, F.; Maggiore, U.; Ferretti, S.; Cobelli, R.; Ferrozzi, F.; Corradi, D.; Salvarani, C.; Buzio, C.
Orofacial granulomatosis treated with low-level laser therapy: A case report
2012-01-01 Merigo, E.; Fornaini, C.; Manfredi, M.; Meleti, M.; Alberici, F.; Corcione, L.; Buzio, C.; Rocca, J. -P.; Ferri, T.; Vescovi, P.
IgG4 immune response in Churg-Strauss syndrome
2012-01-01 Vaglio, A.; Strehl, J. D.; Manger, B.; Maritati, F.; Alberici, F.; Beyer, C.; Rech, J.; Sinico, R. A.; Bonatti, F.; Battistelli, L.; Distler, J. H. W.; Schett, G.; Zwerina, J.
PTPN22 R620W polymorphism in the ANCA-associated vasculitides
2012-01-01 Martorana, D.; Maritati, F.; Malerba, G.; Bonatti, F.; Alberici, F.; Oliva, E.; Sebastio, P.; Manenti, L.; Brugnano, R.; Catanoso, M. G.; Fraticelli, P.; Guida, G.; Gregorini, G.; Possenti, S.; Moroni, G.; Leoni, A.; Pavone, L.; Pesci, A.; Sinico, R. A.; Di Toma, L.; D'Amico, M.; Tumiati, B.; D'Ippolito, R.; Buzio, C.; Neri, T. M.; Vaglio, A.
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis
2013-01-01 Alberici, F.; Palmisano, A.; Urban, M. L.; Maritati, F.; Oliva, E.; Manenti, L.; Ferretti, S.; Cobelli, R.; Buzio, C.; Vaglio, A.
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): A phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC)
2014-01-01 Passalacqua, R.; Caminiti, C.; Buti, S.; Porta, C.; Camisa, R.; Braglia, L.; Tomasello, G.; Vaglio, A.; Labianca, R.; Rondini, E.; Sabbatini, R.; Nastasi, G.; Artioli, F.; Prati, A.; Potenzoni, M.; Pezzuolo, D.; Oliva, E.; Alberici, F.; Buzio, C.
Genetics of ANCA-associated vasculitides: HLA and beyond
2014-01-01 Alberici, F.; Martorana, D.; Bonatti, F.; Gioffredi, A.; Lyons, P. A.; Vaglio, A.
Impact of rituximab trials on the treatment of ANCA-associated vasculitis
2014-01-01 Alberici, F.; Jayne, D. R. W.
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis
2015-01-01 Alberici, F.; Martorana, D.; Vaglio, A.
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
2015-01-01 Roberts, D. M.; Jones, R. B.; Smith, R. M.; Alberici, Federico; Kumaratne, D. S.; Burns, S.; Jayne, D. R. W.
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series
2015-01-01 Roberts, D. M.; Jones, R. B.; Smith, R. M.; Alberici, F.; Kumaratne, D. S.; Burns, S.; Jayne, D. R. W.
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial
2015-01-01 Gianfreda, D.; Nicastro, M.; Galetti, M.; Alberici, F.; Corradi, D.; Becchi, G.; Baldari, G.; De Filippo, M.; Ferretti, S.; Moroni, G.; Foti, R.; Di Gangi, M.; Jeannin, G.; Saffroy, R.; Emile, J. -F.; Buzio, C.; Vaglio, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The role of analytical methods for the determination of trace elements in environmental biomonitors | 1-gen-2002 | Bettinelli, M.; Perotti, M.; Spezia, S.; Baffi, C.; Beone, G. M.; Alberici, F.; Bergonzi, S.; Bettinelli, C.; Cantarini, P.; Mascetti, L. | |
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC) | 1-gen-2007 | Buti, S.; Brighenti, M.; Bongiovanni, C.; Buzio, C.; Chiesa, M. D.; Alberici, F.; Passalacqua, R. | |
Chronically administered immunotherapy with low-dose IL-2 and IFN-α in metastatic renal cell carcinoma: A feasible option for patients with a good prognostic profile | 1-gen-2008 | Vaglio, A.; Alberici, F.; Maggiore, U.; Buti, S.; Potenzoni, D.; Passalacqua, R.; Buzio, C. | |
Peripheral inflammatory arthritis in patients with chronic periaortitis: Report of five cases and review of the literature | 1-gen-2008 | Vaglio, A.; Palmisano, A.; Ferretti, S.; Alberici, Federico; Casazza, I.; Salvarani, C.; Buzio, C. | |
Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-α in patients with renal cell carcinoma | 1-gen-2009 | Pavone, L.; Fanti, G.; Bongiovanni, C.; Goldoni, M.; Alberici, F.; Bonomini, S.; Cristinelli, L.; Buzio, C. | |
Chronic periaortitis associated with membranous nephropathy: Clues to common pathogenetic mechanisms | 1-gen-2010 | Palmisano, A.; Corradi, D.; Carnevali, M. L.; Alberici, F.; Silini, E. M.; Gatti, R.; Allegri, L.; Buzio, C.; Vaglio, A. | |
A cross-sectional study of the Birmingham vasculitis activity score version 3 in systemic vasculitis | 1-gen-2011 | Suppiah, R.; Mukhtyar, C.; Flossmann, O.; Alberici, F.; Baslund, B.; Batra, R.; Brown, D.; Holle, J.; Hruskova, Z.; Jayne, D. R. W.; Judge, A.; Little, M. A.; Palmisano, A.; Stegeman, C.; Tesar, V.; Vaglio, A.; Westman, K.; Luqmani, R. | |
Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index | 1-gen-2011 | Suppiah, R.; Flossmann, O.; Mukhtyar, C.; Alberici, F.; Baslund, B.; Brown, D.; Hasan, N.; Holle, J.; Hruskova, Z.; Jayne, D.; Judge, A.; Little, M. A.; Merkel, P. A.; Palmisano, A.; Seo, P.; Stegeman, C.; Tesar, V.; Vaglio, A.; Westman, K.; Luqmani, R. | |
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: An open-label randomised controlled trial | 1-gen-2011 | Vaglio, A.; Palmisano, A.; Alberici, F.; Maggiore, U.; Ferretti, S.; Cobelli, R.; Ferrozzi, F.; Corradi, D.; Salvarani, C.; Buzio, C. | |
Orofacial granulomatosis treated with low-level laser therapy: A case report | 1-gen-2012 | Merigo, E.; Fornaini, C.; Manfredi, M.; Meleti, M.; Alberici, F.; Corcione, L.; Buzio, C.; Rocca, J. -P.; Ferri, T.; Vescovi, P. | |
IgG4 immune response in Churg-Strauss syndrome | 1-gen-2012 | Vaglio, A.; Strehl, J. D.; Manger, B.; Maritati, F.; Alberici, F.; Beyer, C.; Rech, J.; Sinico, R. A.; Bonatti, F.; Battistelli, L.; Distler, J. H. W.; Schett, G.; Zwerina, J. | |
PTPN22 R620W polymorphism in the ANCA-associated vasculitides | 1-gen-2012 | Martorana, D.; Maritati, F.; Malerba, G.; Bonatti, F.; Alberici, F.; Oliva, E.; Sebastio, P.; Manenti, L.; Brugnano, R.; Catanoso, M. G.; Fraticelli, P.; Guida, G.; Gregorini, G.; Possenti, S.; Moroni, G.; Leoni, A.; Pavone, L.; Pesci, A.; Sinico, R. A.; Di Toma, L.; D'Amico, M.; Tumiati, B.; D'Ippolito, R.; Buzio, C.; Neri, T. M.; Vaglio, A. | |
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis | 1-gen-2013 | Alberici, F.; Palmisano, A.; Urban, M. L.; Maritati, F.; Oliva, E.; Manenti, L.; Ferretti, S.; Cobelli, R.; Buzio, C.; Vaglio, A. | |
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): A phase III, randomized, multicentre trial of the italian oncology group for clinical research (GOIRC) | 1-gen-2014 | Passalacqua, R.; Caminiti, C.; Buti, S.; Porta, C.; Camisa, R.; Braglia, L.; Tomasello, G.; Vaglio, A.; Labianca, R.; Rondini, E.; Sabbatini, R.; Nastasi, G.; Artioli, F.; Prati, A.; Potenzoni, M.; Pezzuolo, D.; Oliva, E.; Alberici, F.; Buzio, C. | |
Genetics of ANCA-associated vasculitides: HLA and beyond | 1-gen-2014 | Alberici, F.; Martorana, D.; Bonatti, F.; Gioffredi, A.; Lyons, P. A.; Vaglio, A. | |
Impact of rituximab trials on the treatment of ANCA-associated vasculitis | 1-gen-2014 | Alberici, F.; Jayne, D. R. W. | |
Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis | 1-gen-2015 | Alberici, F.; Martorana, D.; Vaglio, A. | |
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease | 1-gen-2015 | Roberts, D. M.; Jones, R. B.; Smith, R. M.; Alberici, Federico; Kumaratne, D. S.; Burns, S.; Jayne, D. R. W. | |
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series | 1-gen-2015 | Roberts, D. M.; Jones, R. B.; Smith, R. M.; Alberici, F.; Kumaratne, D. S.; Burns, S.; Jayne, D. R. W. | |
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial | 1-gen-2015 | Gianfreda, D.; Nicastro, M.; Galetti, M.; Alberici, F.; Corradi, D.; Becchi, G.; Baldari, G.; De Filippo, M.; Ferretti, S.; Moroni, G.; Foti, R.; Di Gangi, M.; Jeannin, G.; Saffroy, R.; Emile, J. -F.; Buzio, C.; Vaglio, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile